This selectivity profile matched GHRH, which also does not stimulate the hypothalamic-pituitary-adrenal (HPA) axis

Vial Contents Sterile Vial exterior NOT STERILE One 20 mL sterile vial access needle Two sterile 12 mL Luer Lock syringes Two sterile Luer lock applicators Two sterile syringe tip caps Instructions for Use and Prescribing Information Vial Contents: 14 mL* Withdraw 14 mL to deliver 13.5 mL Rx Only PRINCIPAL DISPLAY PANEL - Kit Carton - 10.5 mL - NDC 47426-502 ZYNRELEF (bupivacaine and meloxicam) extended-release solution 300 mg bupivacaine and 9 mg meloxicam Each mL contains 29.25 mg bupivacaine and 0.88 mg meloxicam Single-Dose Application For Instillation Use Refer to Instructions for Use See Prescribing Information for Dosage, Preparation, and Administration Do Not Substitute Components Use only the supplied components in this kit for preparation Do NOT remove crimp seal NDC 47426-502-02 Store ZYNRELEF kit at 20C to 25C (68F to 77F) with excursions permitted between 15C to 30C (59F to 86F) [See USP Controlled Room Temperature] Protect from light and moisture Each Kit Contains: One single-dose vial containing 300 mg bupivacaine and 9 mg meloxicam in a non-sterile carton

Semaglutide is a different medicine that acts only on GLP-1 receptors, whereas Zepbound contains Tirzepatide, which activates both GIP and GLP-1 receptors to promote weight loss
For a deeper introduction to these compounds, the complete scientific guide to polyphenols in olive oil covers the fundamentals
Always discuss side effects (nausea, vomiting, pancreatitis risk) with your PlexusDx clinician before starting any GLP-1 therapy